He C, Zhang D, He Z
Asian J Androl. 2024; 27(1):4-12.
PMID: 39162186
PMC: 11784953.
DOI: 10.4103/aja202464.
Miao R, Chun H, Feng X, Gomes A, Choi J, Pereira J
Nat Commun. 2022; 13(1):4611.
PMID: 35941168
PMC: 9360400.
DOI: 10.1038/s41467-022-32228-w.
Tsai M, Valent P, Galli S
J Allergy Clin Immunol. 2022; 149(6):1845-1854.
PMID: 35469840
PMC: 9177781.
DOI: 10.1016/j.jaci.2022.04.012.
Annese T, Tamma R, Bozza M, Zito A, Ribatti D
Front Immunol. 2022; 13:794974.
PMID: 35140718
PMC: 8818866.
DOI: 10.3389/fimmu.2022.794974.
Klug L, Corless C, Heinrich M
J Clin Oncol. 2021; 39(15):1674-1686.
PMID: 33797935
PMC: 8274803.
DOI: 10.1200/JCO.20.03245.
Hematopoiesis and Cardiovascular Disease.
Poller W, Nahrendorf M, Swirski F
Circ Res. 2020; 126(8):1061-1085.
PMID: 32271679
PMC: 7153537.
DOI: 10.1161/CIRCRESAHA.120.315895.
Mechanisms of erythrocyte development and regeneration: implications for regenerative medicine and beyond.
Bresnick E, Hewitt K, Mehta C, Keles S, Paulson R, Johnson K
Development. 2018; 145(1).
PMID: 29321181
PMC: 5825862.
DOI: 10.1242/dev.151423.
KIT signaling is dispensable for human mast cell progenitor development.
Dahlin J, Ekoff M, Grootens J, Lof L, Amini R, Hagberg H
Blood. 2017; 130(16):1785-1794.
PMID: 28790106
PMC: 5659818.
DOI: 10.1182/blood-2017-03-773374.
Adult haematopoietic stem cell niches.
Crane G, Jeffery E, Morrison S
Nat Rev Immunol. 2017; 17(9):573-590.
PMID: 28604734
DOI: 10.1038/nri.2017.53.
The spleen microenvironment influences disease transformation in a mouse model of KIT-dependent myeloproliferative neoplasm.
Pelusi N, Kosanke M, Riedt T, Rosseler C, Sere K, Li J
Sci Rep. 2017; 7:41427.
PMID: 28128288
PMC: 5269732.
DOI: 10.1038/srep41427.
Comparison of Human Hematopoietic Reconstitution in Different Strains of Immunodeficient Mice.
Beyer A, Muench M
Stem Cells Dev. 2016; 26(2):102-112.
PMID: 27758159
PMC: 5248550.
DOI: 10.1089/scd.2016.0083.
Eosinophils and Mast Cells in Aspirin-Exacerbated Respiratory Disease.
Steinke J, Payne S, Borish L
Immunol Allergy Clin North Am. 2016; 36(4):719-734.
PMID: 27712766
PMC: 5116300.
DOI: 10.1016/j.iac.2016.06.008.
Growth factor therapy sequesters inflammation in affording neuroprotection in cerebrovascular diseases.
Nguyen H, Aum D, Mashkouri S, Rao G, Vega Gonzales-Portillo J, Reyes S
Expert Rev Neurother. 2016; 16(8):915-26.
PMID: 27152762
PMC: 5057178.
DOI: 10.1080/14737175.2016.1184086.
MiR-34a-5p promotes the multi-drug resistance of osteosarcoma by targeting the CD117 gene.
Pu Y, Zhao F, Wang H, Cai W, Gao J, Li Y
Oncotarget. 2016; 7(19):28420-34.
PMID: 27056900
PMC: 5053736.
DOI: 10.18632/oncotarget.8546.
Chicken stem cell factor enhances primordial germ cell proliferation cooperatively with fibroblast growth factor 2.
Miyahara D, Oishi I, Makino R, Kurumisawa N, Nakaya R, Ono T
J Reprod Dev. 2016; 62(2):143-9.
PMID: 26727404
PMC: 4848571.
DOI: 10.1262/jrd.2015-128.
Conditional Deletion of Kit in Melanocytes: White Spotting Phenotype Is Cell Autonomous.
Aoki H, Tomita H, Hara A, Kunisada T
J Invest Dermatol. 2015; 135(7):1829-1838.
PMID: 25734811
DOI: 10.1038/jid.2015.83.
The Role of Mast Cells in Molding the Tumor Microenvironment.
Rigoni A, Colombo M, Pucillo C
Cancer Microenviron. 2014; 8(3):167-76.
PMID: 25194694
PMC: 4715001.
DOI: 10.1007/s12307-014-0152-8.
Involvement of c-KIT mutation in the development of gastrointestinal stromal tumors through proliferation promotion and apoptosis inhibition.
Ma Y, Yu S, He X, Xu Y, Wu F, Xia Y
Onco Targets Ther. 2014; 7:637-43.
PMID: 24833907
PMC: 4014364.
DOI: 10.2147/OTT.S60458.
Ex vivo expansion of functional human UCB-HSCs/HPCs by coculture with AFT024-hkirre cells.
Khan M, Ali I, Jiao W, Wang Y, Masood S, Zubair Yousaf M
Biomed Res Int. 2014; 2014:412075.
PMID: 24719861
PMC: 3955665.
DOI: 10.1155/2014/412075.
Mast cells as a potential prognostic marker in prostate cancer.
Taverna G, Giusti G, Seveso M, Hurle R, Colombo P, Stifter S
Dis Markers. 2013; 35(6):711-20.
PMID: 24324287
PMC: 3844173.
DOI: 10.1155/2013/478303.